en

PRODUCT DETAIL

Abiraterón STADA 250 mg filmom obalené tablety

Code 8625D
MA number 44/0247/21-S
Product Form: tbl flm 112x1x250 mg (blis.Al/PVC/PE/PVDC-jednotliv.dáv.)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
MAH, country: STADA Arzneimittel AG, Germany
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L02 ENDOCRINE THERAPY
L02B HORMONE ANTAGONISTS AND RELATED AGENTS
L02BX Other hormone antagonists and relate agents
L02BX03 Abiraterone
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 22.10.2021
Validity: 22.10.2026
PIL: PIL_Abiraterón STADA 250 mg filmom obalené tablety_04.2022.pdf  
SPC: SPC_Abiraterón STADA 250 mg filmom obalené tablety_06.2022.pdf  
Safety feature Yes
Data update: 10.06.2022
eu-flag.png sk-flag.png